Cover Image

HARDBACK
$52.95



View/Hide Left Panel

Table A11–1 Disease Scenarios for Women and Men for HPV Infection

 

No. of Cases

% of Cases

Committee HUI Values

Duration (years)

WOMEN

 

Genital warts, limited

237,500

47.5%

 

minor physical discomfort

 

0.95

0.2500 (3 months)

Genital warts, limited but recurring

237,500

47.5%

 

minor physical discomfort (2 recurrences per year for 10 years)

 

0.90

0.5000 (6 months/year)

Genital warts, extensive

12,500

2.5%

 

same physical discomfort

 

0.85

0.2500 (3 months)

Genital warts, extensive and recurring

12,500

2.5%

 

some physical discomfort (2 recurrences per year for 10 years)

 

0.85

0.5000 (6 months/year)

Cervical dysplasia

50,000

10.0%

0.97

1.5000 (18 months)

All Cancers: assume average 25-year lag from infection

Cervical cancer—carcinoma in situ

25,000

5.0%

 

treatment phase

 

0.80

0.3333 (4 months)

posttreatment phase (follow-up)

 

0.97

2.0000 (2 years)

Cervical cancer—locally invasive at diagnosis

5,000

1.0%

 

treatment phase (surgery, radiation, chemotherapy)

 

0.79

0.3333 (4 months)

posttreatment phase (follow-up)

 

0.90

16.7349 (years remaining)

Cervical cancer—advanced at diagnosis

2,500

0.5%

 

treatment phase (surgery, radiation, chemotherapy)

 

0.62

0.3333 (4 months)

posttreatment phase (follow-up and sequelae e.g., infertiity, sexual dysfunction, urinary dysfunction)

 

0.62

3.0000 (3 years)

premature death (by 3 years after diagnosis)

 

0.00

15.7265 (years lost)



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement